Phase Ib
Entity.
- Evidence
- 30 documents · 13 separate publishers
- Standing
- Added automatically from coverage
- Time
- first seen 11 Mar 2026, last seen 22 Oct 2026
- Measured
- 0% of mentions say something specific about it; the rest only name it
- As of
- 23 Oct 2026
Where this comes from
- AllSci News · 2026-10-13 · First Tracks' ANB033 meets histologic endpoints in Phase Ib celiac disease trial (opens the source in a new tab)
- The Clinical Trial Vanguard · 2026-10-06 · Lundbeck’s Lu AF28996 gains 2+ hours daily ON-time in Parkinson’s Phase Ib (opens the source in a new tab)
- Clinical Trials Arena · 2026-10-06 · First patient dosed in Vial’s Phase Ib trial of IL-13 x TSLP antibody (opens the source in a new tab)
- The Clinical Trial Vanguard · 2026-10-02 · Lundbeck presents MSA trial baseline data, Lu AF28996 Phase Ib results at MDS 2026 (opens the source in a new tab)
- Clinical Trials Arena · 2026-09-25 · Clywedog reports final Phase Ib trial results for balomenib (opens the source in a new tab)
- Clinical Trials Arena · 2026-09-22 · Alkermes reports positive top-line Phase Ib trial data for ALKS 7290 (opens the source in a new tab)